METHYL 2-OXO-3-((2'-(5-OXO-2,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)-(1,1'-BIPHENYL)-4-YL)METHYL)-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOLE-4-CARBOXYLATE
UNII 6N6B4U3BSE
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 2-oxo-3-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-yl)methyl)-2,3-dihydro-1h-benzo(d)imidazole-4-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6N6B4U3BSE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1403474-78-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H18N4O5 QTOITPRMCZPASX-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 2-oxo-3-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-yl)methyl)-2,3-dihydro-1h-benzo(d)imidazole-4-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.